About VetDC
VetDC is a company based in Fort Collins (United States) founded in 2010. VetDC has raised $5.49 million across 4 funding rounds. VetDC has completed 1 acquisition, including Pathway Therapeutics. VetDC offers products and services including TANOVEA®-CA1 and VDC-597. VetDC operates in a competitive market with competitors including ImpriMed, CanFel Therapeutics, Animal Life Sciences, Vetco Pharmaceuticals and Blue Horizon Biotech, among others.
- Headquarter Fort Collins, United States
- SectorsHealthcare
- Email••••••••
- Website vet-dc.com
- Social LinkedIn Facebook
- Total Equity Funding$5.49M (USD)
in 4 rounds
- Latest Funding Round$2.1M (USD), Series A
Mar 2015
- Investments & Acquisitions
Products & Services of VetDC
VetDC offers a comprehensive portfolio of products and services, including TANOVEA®-CA1 and VDC-597.
Injection for treating canine lymphoma in pets effectively.
Therapy targeting various cancers in companion animals.
Funding Insights of VetDC
VetDC has successfully raised a total of $5.49M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $2.1 million completed in March 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5.49M
- Total Rounds 4
- Last Round Series A — $2.1M
- First Round $1.48M
(Nov 2012)
All 4 funding rounds of VetDC with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2015 | $2.1M | Series A | – | – | – |
| Sep 2014 | $587,313 | Seed | – | – | – |
| May 2013 | $1.33M | Seed | – | – | – |
| Nov 2012 | $1.48M | Seed | – | – | – |
People of VetDC
11 people are tracked at VetDC (6 in leadership, 5 in board & advisors).
| Name | Role | Group |
|---|---|---|
Steven Roy | President, CEO & Board of Directors | Leadership |
Ann R. Donoghue | Senior Director, Product Development & Regulatory Affairs | Leadership |
Cathy Gust | Head of Operations | Leadership |
Terry Opgenorth | Chief Scientific Officer, Board Observer | Leadership |
Douglas G. Johnson | Senior Director, Pharmaceutical Operations | Leadership |
Douglas H. Thamm | Head of Clinical Development | Leadership |
Richard C. Duke | Board Observer | Board & advisors |
T. Richard Fort | Board Member | Board & advisors |
Steve B. Warnecke | Chairman of the Board | Board & advisors |
Mark Lupa | Board Member | Board & advisors |
John Q. Adams | Board Advisor | Board & advisors |
Complete people profiles for VetDC
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by VetDC
VetDC has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Pathway Therapeutics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Isoform-specific PI3K inhibitors are developed for oncology and inflammation. | pathwaytx.com | San Francisco, United States | 2008 | Aug 2013 | •••• |
Complete acquisition details for VetDC
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of VetDC
4 dated milestones of VetDC across 5 years, from founding to its latest funding, stage changes and deals.
- Founded VetDC is founded.
- Funding First funding round of $1.5M.
- Acquisition Acquires Pathway Therapeutics.
- Funding Latest funding round, Series A, of $2.1M.
Competitors of VetDC
VetDC operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ImpriMed, CanFel Therapeutics, Animal Life Sciences, Vetco Pharmaceuticals and Blue Horizon Biotech, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| imprimedicine.com | 2017 | Palo Alto, United States | $34.92M | 14 | Provider of precision medicines for veterinary cancer | |
| canfeltherapeutics.com | 1999 | Torrance, United States | – | – | Cancer therapeutics for animals are developed using innovative platforms. | |
| animallifesciences.com | 2018 | New York, United States | $198,800 | – | Developer of pet food, supplements and therapeutics to treat cancer in animals | |
| vetcogroup.com | 2012 | Sanchong, Taiwan | – | – | Offers comprehensive pharmaceutical products for treating cancer in animals. | |
| bluehorizonbiotech.com | 2020 | United States | – | – | Develops innovative veterinary therapeutics for cancer treatment. |
Detailed competitors of VetDC
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of VetDC
The website of VetDC (vet-dc.com) receives about 2.4K visits a month.
- Monthly visits2.4K
▲ 104.4% vs previous month
Websites whose visitors overlap most with VetDC. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
csuanimalcancercenter.org | csuanimalcancercenter.org | 100% | – | #3,159,909 | – |
vetcancersociety.org | vetcancersociety.org | 52% | – | #3,930,401 | – |
Latest news on Vetdc
Complete news archive for VetDC
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to VetDC
10 companies that operate in the same segment as VetDC (Veterinary Digital Health), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Practice and prescription management software is provided for veterinary professionals. | 2010 | Portland, Oregon, United States | USD 291.64 M | – | – | |
Animal medicines, vaccines, and diagnostics are manufactured and supplied. | 2012 | Brussels, Brussels-capital Region, Belgium | – | – | – | |
Veterinary pharmacy services are delivered by VetSource to practices. | 2005 | Portland, Oregon, United States | USD 81.25 M | – | – | |
Animal health therapeutics are developed and supplied globally by Ceva. | 1999 | Libourne, Nouvelle-aquitaine, France | USD 214.35 M | – | – | |
Digital platform for pet insurance | 2020 | Stockholm, Sweden | USD 114.08 M | – | – | |
App based platform providing veterinary services and clinical management solutions for veterinarians | 2018 | Beverly Hills, California, United States | USD 58.81 M | – | – | |
Online client communication platform for veterinary doctors | 2013 | San Diego, California, United States | USD 14.11 M | USD 14.38 M | 1 | |
Virtual veterinary care is provided via an app platform. | 2018 | Los Angeles, California, United States | USD 210 M | – | 163 | |
Comprehensive customer engagement platform for veterinary clinics is provided. | 2015 | Austin, Texas, United States | USD 50.3 M | – | – | |
Veterinary appointments are booked via an online platform. | 2017 | Brooklyn, New York, United States | USD 243 M | – | 64 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about VetDC
VetDC was founded in 2010 and raised its 1st funding round 2 years after it was founded.
VetDC is headquartered in Fort Collins, United States. It is registered at Fort Collins, Colorado, United States.
VetDC is a funded company, having raised a total of $5.49M across 4 funding rounds to date. The company's 1st funding round was a Seed of $1.48M, raised on Nov 2012.
VetDC was founded in 2010 in Fort Collins, United States, and operates in the veterinary oncology sector. Anticancer treatments for animals are being advanced by the company, with a primary focus on canine lymphoma. A Series-B funding round was recently completed to support FDA approval and the launch of Tanovea as a chemotherapy alternative for dogs. Additional therapies for animal cancers remain in the development pipeline.
VetDC's top competitors include ImpriMed, Animal Life Sciences and CanFel Therapeutics.
VetDC offers TANOVEA®-CA1 and VDC-597.
VetDC has made 1 acquisition, including Pathway Therapeutics.